Optimize Your Clinical Lab with Streamlined Molecular Workflows
Explore a hypothetical scenario demonstrating how integrated workflows have the potential to help enhance efficiency, accuracy, and patient care
Today’s Clinical Lab is a reader-centric publication that keeps clinical professionals up to date with today’s rapidly changing lab industry with in-depth and timely editorial content and resources, including clinical industry news and insights into the latest trends, technologies, and techniques in the clinical lab.
ViewFull ProfileLearn about ourEditorial Policies.
A challenging day in the oncology ward
It’s not hard to imagine this scenario: In the midst of a particularly severe flu season, an oncology ward faces an influx of cancer patients exhibiting respiratory symptoms. For these immunocompromised individuals, differentiating between COVID-19, influenza, and respiratory syncytial virus (RSV) is critical for effective treatment and infection control. Each of these viral infections presents unique challenges, particularly for patients already weakened by their respective oncology treatments. A patient being treated for cancer begins to show signs of respiratory illness, prompting an urgent need for diagnostic clarity to help prevent complications and further spread of infection. Delays in getting test results back to the oncology care team could negatively impact the patient.
For vulnerable patients, rapid diagnosis can mean the difference between effective treatment and severe complications. Without implementing integrated diagnostic workflows, labs often operate with a fragmented system, where different platforms manage the ordering, processing, and reporting of tests. This lack of integration can result in considerable delays. For patients and healthcare providers, this disjointed process can mean waiting days for results. Such delays increase risks, often leading to postponed treatments and extended isolation measures—a burden for patients already facing the challenges of cancer treatment. Delayed results can also add preventable costs to patient outcomes and to the health system budget, especially if interventions are delayed.
The inability to quickly and accurately diagnose respiratory infections not only compromises patient care but also places additional stress on healthcare providers. In an environment where the focus should be on healing, the uncertainty and frustration of waiting for results can detract from the overall experience of care. In our oncology ward example, recognizing the importance of timely results for their vulnerable patient population demonstrates the critical need for fast diagnostic turnaround times in the clinical laboratory. Integrated workflows could help support more efficient processes to streamline diagnostics and improve patient outcomes, ultimately supporting the oncology team’s ability to manage patient care more effectively.
Note: This is a hypothetical example of workflow implementation. Actual results may vary based on numerous factors not covered in this example. All tools and techniques described are for in vitro diagnostic use only.
How integrated systems can improve treatment plans and outcomes for immunocompromised patients
Thermo Fisher Scientific has the following clinical lab solutions to help diagnose respiratory infections in immunocompromised patients:
- Diomni™ Enterprise Dx Software
- KingFisher™ Dx sample purification systems
- QuantStudio™ Dx real-time PCR systems
- Diagnostic kitted assays, such as the TaqPath™ COVID-19 Diagnostic PCR Kit
The integration of these solutions can help labs to streamline the entire diagnostic workflow, from sample extraction to result reporting. Diomni Dx software allows the consolidation of the modular diagnostic workflow into a single platform, substantially reducing overall testing time. By automating sample management and traceability, a clinical lab can aim to minimize manual errors and expedite the process from specimen collection to diagnosis.
The KingFisher Dx sample purification system automates the extraction of viral RNA and DNA, enabling high-quality samples and helping to minimize manual errors. The system’s high-throughput processing capabilities support the increased volume of tests during peak flu season. This ability to automate and scale up sample processing helps to prepare patient samples swiftly for PCR testing, allowing for rapid results that are critical for timely decision-making. With automation in sample processing, our hypothetical clinical lab is free to focus on other essential tasks, knowing that KingFisher is efficiently handling the extraction and purification processes.
QuantStudio Dx Real-Time PCR systems enable multiplex PCR testing, allowing for the simultaneous detection of multiple pathogens—including COVID-19, influenza, and RSV—from a single sample. This capacity is particularly important during flu season when the demand for rapid testing soars. As a result, the time to results for the oncology patient can be significantly reduced with these improvements, allowing clinicians to make timely treatment decisions. Diagnostic assays further support the lab’s capacity to run high-quality molecular diagnostics efficiently. With its ability to facilitate reliable and rapid identification of respiratory viruses, an oncology team can receive confirmed results within hours. This facilitates treatment for RSV, reducing the risk of complications for the patient.
A major advantage of integrated systems is the connectivity between clinicians and the lab, facilitated by Diomni Dx software. Rapid access to patient RSV diagnosis allows medical teams to quickly adapt their treatment approach based on the latest data. Diagnostic assays have the potential to streamline the testing process by offering accurate, validated, and high-throughput molecular assays specifically designed for respiratory viruses like COVID-19, influenza, and RSV. The integration of these assays into the workflow not only improves the accuracy of results but also enhances the speed at which they are available to medical professionals.
The power of integrated technologies in high-risk settings
By utilizing Thermo Fisher Scientific workflow solutions, the hypothetical oncology lab is able to unify its workflow, eliminating the need for multiple, disjointed systems. This unification allows for smoother processes and fewer delays, as all tests for specified respiratory infections are processed through a single, cohesive platform. The oncology team can benefit from streamlined operations, which may have enhanced overall efficiency. Multiplexing flexibility allows for the simultaneous detection of multiple respiratory pathogens, further minimizing patient stress and supporting timely diagnoses.
The automation capabilities of the KingFisher Dx Sample Purification systems can be applied to scale effectively to manage the increased testing volumes during flu season. By automating sample processing, KingFisher sample purification systems can enable labs like this oncology clinical lab to handle a high volume of tests efficiently without sacrificing quality. This scalability is vital for processing patient samples without delays and reducing workflow bottlenecks. The streamlined processes provided by KingFisher sample purification systems can thus contribute to a quicker turnaround time for results.
QuantStudio Dx Real-Time PCR systems enable oncology labs to conduct multiplex testing for various targets, including COVID-19, influenza, and RSV, all from a single patient sample. This capacity is especially important during flu season when the demand for rapid reporting of test results is at its highest. By minimizing the number of samples needed, the burden on the patients is reduced, and the speed of diagnosis can be enhanced considerably.
The integration features of Diomni Dx software allow for centralized data management, enhancing compliance and decision-making within clinical labs. The ability to track samples and results through a unified platform not only streamlines operations but also supports regulatory compliance by providing clear documentation and traceability.
How integration can support patient care
The integration of KingFisher Dx, QuantStudio Dx, and Diomni Dx software improves the efficiency of diagnostic workflows, reducing turnaround times drastically. For a cancer patient experiencing respiratory symptoms, a quick RSV diagnosis enables the oncology team to start treatment without delay, reducing the risk of complications that could arise from prolonged illness. Integrated systems can manage the higher testing volumes during flu season effectively, facilitating timely results for patients.
The impact of these integrated workflows extends beyond individual patients to the overall efficiency of the healthcare team. With timely access to test results, clinicians can make informed decisions, coordinate care more effectively, and implement infection control measures without unnecessary delays. In an environment where every minute counts, the integration of these technologies not only enhances patient care but also increases the overall efficiency of the healthcare team.
Patients and their families know that their healthcare providers have the tools necessary to make timely, accurate diagnoses. This emotional aspect of care is vital, especially where high-risk patients are already navigating a myriad of challenges.
The seamless integration of technology can allow for better resource allocation within the clinical labs. With automated systems handling routine tasks, lab personnel can focus on complex cases that require more specialized attention.
The future of rapid respiratory testing
Thermo Fisher Scientific’s integrated technologies—including KingFisher Dx sample purification systems, QuantStudio Dx real-time PCR systems, Diomni Enterprise Dx Software, and diagnostic knitted assays—provide clinical labs with an effective solution to enhance workflow efficiency and diagnostic accuracy, especially in high-risk oncology settings. By adopting these integrated systems, clinical labs can automate molecular workflows and scale operations to address the demands of today’s healthcare challenges. This strategic implementation helps ensure that critical tests for COVID-19, influenza, and RSV are processed quickly and accurately, allowing timely diagnoses that can help improve patient outcomes.
As healthcare continues to evolve, the need for integrated solutions that prioritize patient care and operational efficiency will only grow. The experiences of the hypothetical oncology ward demonstrate that the right technologies can transform diagnostic workflows, reduce the burden on patients, and empower healthcare teams to provide excellent care.
In the dynamic and often challenging environment of high-risk patient care, leveraging integrated technologies not only enhances operational efficiency but also prioritizes patient care. The lessons learned from the implementation of these technologies underscore the importance of collaboration between clinical labs and healthcare teams. As we move forward, embracing integrated clinical workflows will help healthcare providers meet the complex needs of their patients.
By investing in integrated molecular workflows, clinical labs can create a more responsive, effective, and compassionate healthcare environment. Ultimately, this commitment to innovation and excellence can help ensure that patients receive timely and accurate care when they need it most.
Learn more about integrated molecular workflows or request a quote for real-time PCR solutions.